Outlook
2023
Annual Industry Ranking And Forecast
Scrip 100
The full Scrip 100 data set for 2023 is now available and includes data on R&D spending, total revenues, employee numbers and sales for the top 100 biopharmaceutical companies (based on FY 2021).
If you are a subscriber, you may download the data in Excel format.
Pfizer Leads An Unusual Year For The Scrip 100
Pfizer catapulted back into the lead in the pharmaceutical rankings on the strength of COVID-19 revenues while BioNTech and Moderna both made the list for the first time.
Infographic: Top 100 Pharma Companies
The Scrip 100 universe gathers FY2021 financial performance data and compares the activities of the top 100 biopharma businesses, ranked by pharma sales.
Chapter sponsored by:
Decentralized Clinical Trials:
Driving Economic Value In
Clinical Development
Clinical trials are expensive, and the attrition rate can be brutal. Trial sponsors want to know that, if they take DCTs on board, their bottom line is going to benefit too.
Outlook 2023 e-Book
Download a PDF copy of the Outlook 2023 collection, including Scrip 100 league tables.
Scrip 100 Ranking
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Article
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.